May 22, 2025
Combined General Meeting of May 21, 2025
Press Release – Approval of all resolutions submitted by the Board of Directors, including the unconsolidated and consolidated financial statements…
Pharmaceuticals, Biotechnology and Life Sciences
Press Release – Approval of all resolutions submitted by the Board of Directors, including the unconsolidated and consolidated financial statements…
MEDIA RELEASE Pyzchiva® first ustekinumab biosimilar in Europe commercially available in pre-filled pen (autoinjector), offering improved self-administration experience for better…
Media ReleaseCOPENHAGEN, Denmark; May 21, 2025Genmab A/S (Nasdaq: GMAB) announced today that its Chief Development Officer Judith Klimovsky will participate…
SOUTH SAN FRANCISCO, Calif., May 20, 2025 (GLOBE NEWSWIRE) — Vaxart, Inc. (Nasdaq: VXRT) (the “Company” or “Vaxart”) today announced that…
TEL AVIV, Israel, May 20, 2025 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) (“Teva”) announced today…
VANCOUVER, British Columbia, May 20, 2025 (GLOBE NEWSWIRE) — Segra International (“Segra”), a global leader in cannabis agriculture technology, proudly…
TEL AVIV, Israel, May 20, 2025 (GLOBE NEWSWIRE) — Teva Pharmaceuticals (NYSE and TASE: TEVA) today announced that Fitch Ratings Agency…
TrialWire™ is the risk-share pay-per-enrolled AI and algorithm-powered patient recruitment Platform built on Salesforce Health Cloud for industry-leading patient data…
Cash runway into Q3 2026AFFIRM-1 Phase 3 clinical trial of BNC-210 in social anxiety disorder on track for topline readout…
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), May 20, 2025 – GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated…